OVERVIEW
Join us for a live, interactive, 90-minute symposium focused on the use of immunotherapy for the treatment of nonmelanoma skin cancers, specifically cutaneous squamous cell carcinoma (CSCC) and basal cell carcinoma (BCC). Expert faculty will discuss the rationale for the use of immunotherapy in CSCC and BCC, recent clinical trial data, as well as guidelines and recommendations for incorporating immunotherapy for these skin cancers into clinical practice. Patient case vignettes will be used to emphasize the importance of the patient voice in making clinical decisions. Participants will be given the opportunity to answer polling questions throughout the program that will help them strategize considerations for treating and managing patients with CSCC and BCC as well as emphasizing the importance of the role of the multidisciplinary team to optimize care for patients.
IMPORTANT INFO
This CME symposium will be offered both in-person and virtually. Please note: you will need to be a registered attendee of ESMO 2023 in order to participate.
GOAL STATEMENT
The goal of this activity is for learners to be better able to recognize and leverage the patient voice in the comprehensive and multidisciplinary care of patients with nonmelanoma skin cancers.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the [LIST][ITEM]Role of immunotherapy in the treatment of nonmelanoma skin cancers[/LIST] Have greater competence related to [LIST][ITEM]Assessing patients with nonmelanoma skin cancers [ITEM]Integrating the patient voice in creating personalized care plans for nonmelanoma skin cancers [ITEM] Mitigating adverse events associated with immunotherapies used for nonmelanoma skin cancers [/LIST] Demonstrate greater confidence in their ability to [LIST][ITEM]Leverage the patient voice in the multidisciplinary care of patients with nonmelanoma skin cancers [/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO][MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.5 [bold][italic]AMA PRA Category 1 Credits™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
IFEMA Madrid
Avda. del Partenón, 5
Madrid, Spain, 28042
Supported by an independent educational grant from [bold]Regeneron Pharmaceuticals, Inc.[/bold]